Literature DB >> 9811526

Monocyte chemoattractant protein 1 (MCP-1) gene expression in dilated cardiomyopathy.

M H Lehmann1, H Kühnert, S Müller, H H Sigusch.   

Abstract

The cytotoxic action of leukocytes may be a most probable cause of cardiac myocyte damage seen in chronic myocarditis and dilated cardiomyopathy (DCM). The migration and tissue infiltration of leukocytes is regulated by chemotactic cytokines. Recently, the presence of monocyte chemoattractant protein 1 (MCP-1) messenger RNA has been demonstrated in endomyocardial biopsy tissue obtained from patients with DCM. This chemokine could contribute to enhanced leukocyte recruitment and activation resulting in chronic damage of cardiomyocytes. Accordingly, we sought to determine whether the severity of left ventricular dysfunction in DCM is associated with quantitative alterations of MCP-1 messenger RNA and MCP-1 protein in endomyocardial biopsy tissue. A group of DCM patients with low to moderate impairment of left ventricular function (ejection fraction 45.3+/-2.3%, n=7) was compared to patients with severe left ventricular dysfunction (ejection fraction 25.5+/-3.1%, n=7). MCP-1 messenger RNA expression was determined by quantitative polymerase chain reaction. MCP-1 protein and the presence of infiltrating inflammatory cells were detected by immunohistochemistry. DCM patients with severe left ventricular dysfunction showed a 2.35 fold higher MCP-1 messenger RNA expression when compared to DCM patients with less severe dysfunction (P=0.0229). Positive immunohistochemical staining for MCP-1 was found in all seven patients with severe left ventricular dysfunction and was particularly distinct within the cardiac interstitum. In five of seven patients with less severe systolic dysfunction, MCP-1 protein was found, but was less pronounced and distributed in patchy interstitial areas, close to intramyocardial vessels. Furthermore, there was a consistent trend toward a higher infiltration of inflammatory cells in DCM patients with lower ejection fraction. In conclusion, MCP-1 is dynamically regulated in DCM related deterioration of left ventricular function. This mechanism might contribute to myocyte damage via infiltrated and activated monocytes. Copyright 1998 Academic Press.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9811526     DOI: 10.1006/cyto.1998.0354

Source DB:  PubMed          Journal:  Cytokine        ISSN: 1043-4666            Impact factor:   3.861


  12 in total

Review 1.  Molecular genetics of cardiomyopathies.

Authors:  G Shah; R Roberts
Journal:  J Nucl Cardiol       Date:  2000 Mar-Apr       Impact factor: 5.952

2.  Enhanced expression and production of monocyte chemoattractant protein-1 in myocarditis.

Authors:  K Fuse; M Kodama; H Hanawa; Y Okura; M Ito; T Shiono; S Maruyama; S Hirono; K Kato; K Watanabe; Y Aizawa
Journal:  Clin Exp Immunol       Date:  2001-06       Impact factor: 4.330

3.  Cardiac remodelling in end stage heart failure: upregulation of matrix metalloproteinase (MMP) irrespective of the underlying disease, and evidence for a direct inhibitory effect of ACE inhibitors on MMP.

Authors:  D Reinhardt; H H Sigusch; J Hensse; S C Tyagi; R Körfer; H R Figulla
Journal:  Heart       Date:  2002-11       Impact factor: 5.994

4.  Secondary lymphoid tissue chemokine (SLC/CCL21)/CCR7 signaling regulates fibrocytes in renal fibrosis.

Authors:  Norihiko Sakai; Takashi Wada; Hitoshi Yokoyama; Martin Lipp; Satoshi Ueha; Kouji Matsushima; Shuichi Kaneko
Journal:  Proc Natl Acad Sci U S A       Date:  2006-09-11       Impact factor: 11.205

5.  Evidence for an active inflammatory process in the hibernating human myocardium.

Authors:  Nikolaos G Frangogiannis; Sarah Shimoni; Su Min Chang; Guofeng Ren; Kesavan Shan; Constandina Aggeli; Michael J Reardon; George V Letsou; Rafael Espada; Mahesh Ramchandani; Mark L Entman; William A Zoghbi
Journal:  Am J Pathol       Date:  2002-04       Impact factor: 4.307

6.  Identification of cardiac troponin I sequence motifs leading to heart failure by induction of myocardial inflammation and fibrosis.

Authors:  Ziya Kaya; Stefan Göser; Sebastian J Buss; Florian Leuschner; Renate Ottl; Jin Li; Mirko Völkers; Stefan Zittrich; Gabriele Pfitzer; Noel R Rose; Hugo A Katus
Journal:  Circulation       Date:  2008-10-27       Impact factor: 29.690

7.  Interferons in enteroviral heart disease: modulation of cytokine expression and antiviral activity.

Authors:  Albert Heim; Sabine Weiss
Journal:  Med Microbiol Immunol       Date:  2003-09-12       Impact factor: 3.402

8.  Modified vaccinia virus ankara triggers chemotaxis of monocytes and early respiratory immigration of leukocytes by induction of CCL2 expression.

Authors:  Michael H Lehmann; Wolfgang Kastenmuller; Judith D Kandemir; Florian Brandt; Yasemin Suezer; Gerd Sutter
Journal:  J Virol       Date:  2009-01-07       Impact factor: 5.103

9.  Pheochromocytoma-induced cardiomyopathy is modulated by the synergistic effects of cell-secreted factors.

Authors:  Hector R Mobine; Aaron B Baker; Libin Wang; Hiroko Wakimoto; Kurt C Jacobsen; Christine E Seidman; J G Seidman; Elazer R Edelman
Journal:  Circ Heart Fail       Date:  2009-02-10       Impact factor: 8.790

Review 10.  Chemokines and Heart Disease: A Network Connecting Cardiovascular Biology to Immune and Autonomic Nervous Systems.

Authors:  Veronica Dusi; Alice Ghidoni; Alice Ravera; Gaetano M De Ferrari; Laura Calvillo
Journal:  Mediators Inflamm       Date:  2016-05-03       Impact factor: 4.711

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.